Compare CNXU & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNXU | LCNB |
|---|---|---|
| Founded | N/A | 1877 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 215.9M | 223.1M |
| IPO Year | 2025 | 1999 |
| Metric | CNXU | LCNB |
|---|---|---|
| Price | $4.46 | $19.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 266.9K | 23.6K |
| Earning Date | N/A | 04-22-2026 |
| Dividend Yield | N/A | ★ 5.43% |
| EPS Growth | N/A | ★ 68.04 |
| EPS | N/A | ★ 0.84 |
| Revenue | N/A | ★ $6,445,000.00 |
| Revenue This Year | N/A | $8.50 |
| Revenue Next Year | N/A | $3.66 |
| P/E Ratio | ★ N/A | $22.58 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.43 | $14.31 |
| 52 Week High | $13.66 | $21.32 |
| Indicator | CNXU | LCNB |
|---|---|---|
| Relative Strength Index (RSI) | 26.71 | 46.01 |
| Support Level | N/A | $18.77 |
| Resistance Level | $10.41 | $20.48 |
| Average True Range (ATR) | 0.74 | 0.44 |
| MACD | -0.28 | -0.08 |
| Stochastic Oscillator | 1.97 | 29.68 |
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.